United States DC Circuit
In re: Lorazepam & Clorazepate Antitrust Litig., 08-5044
In an action claiming that defendants entered into exclusive licensing agreements enabling defendant to raise the prices the insurance companies paid for two prescription anti-anxiety medications, judgment for plaintiff is vacated where plaintiffs' self-funded customers were required to be counted as parties for diversity of citizenship purposes, and thus the district court needed to examine the issue of its own jurisdiction.
Appellate Information
- Decided 01/18/2011
- Published 01/18/2011
Judges
- A. Raymond Randolph
Court
- United States DC Circuit
Counsel
- For Appellant:
- Jonathan M. Jacobson, Martin R. Lueck